June 2019 newsletter
Therapeutic protein degradation by design; Presentations from recent meetings; Review of Efficient Drug Discovery Through Connected Chemistry symposium; New website
We have made great strides towards our new product in the last six months. Find out more about our progress and what is left to do ahead of our planned beta release in early 2017.
Mark Mackey, Cresset CSO, explains why we chose Lead Finder as our preferred docking engine for structure-based design and to expand our virtual screening capabilities.
Send us your purchase order for an annual license for Lead Finder by 31st December 2016 and we will issue a 15 month license, which means you get 3 months free. Try a free evaluation.
From October 2016, Spark users will benefit from monthly releases of updated eMolecules derived reagent databases. The rolling updates are intended to provide the very best availability information on the reagents that you wish to employ.
Save the date in your diary to hear speakers from the following industry leading orgnaizations, with more still to be confirmed: